Antibody-mediated pure red cell aplasia related with epoetin-beta pegol (C.E.R.A.) as an erythropoietic agent: case report of a dialysis patient

BACKGROUND: Erythropoietin-stimulating agents (ESAs) are used to treat anemia in patients with chronic kidney disease, enabling maintenance of stable hemoglobin levels and eliminating the need for multiple transfusions. Epoetin-beta pegol (C.E.R.A.) is a continuous erythropoietin receptor activator...

Descripción completa

Detalles Bibliográficos
Autores principales: Shingu, Yasuki, Nakata, Tomohiro, Sawai, Shinji, Tanaka, Hisaya, Asai, Osamu, Tamagaki, Keiichi, Nakatani, Kimihiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7362491/
https://www.ncbi.nlm.nih.gov/pubmed/32664894
http://dx.doi.org/10.1186/s12882-020-01934-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7362491/
https://www.ncbi.nlm.nih.gov/pubmed/32664894
http://dx.doi.org/10.1186/s12882-020-01934-2

Ejemplares similares